US respiratory illness vaccination and prevention guidance

Health experts and specialists are providing guidance for the upcoming respiratory illness season, focusing on influenza and COVID-19.

Initial guidance emphasized the timing of vaccinations. While the FDA had determined vaccine compositions, formal federal recommendations from the CDC’s Advisory Committee on Immunization Practices were still pending. Major medical organizations, including the American Academy of Pediatrics, recommended routine vaccination, with insurers expected to cover costs. Epidemiologists suggested waiting until mid-September or mid-October for flu shots to ensure protection lasts through the peak season between December and March.

As the season approached, emphasis shifted toward individual risk assessment and the importance of medical intervention. Experts highlighted that high-risk groups, such as older adults, young children, and those with chronic conditions like asthma or diabetes, should consult providers. Additionally, the effectiveness of antiviral treatments was noted as being highly dependent on timing, with flu treatments working best within two days and COVID-19 treatments requiring initiation within five to seven days of symptom onset.